Literature DB >> 8150522

Practical measures to control device-related bacterial infections.

J W Costerton1, A E Khoury, K H Ward, H Anwar.   

Abstract

Direct examination of medical devices that have been foci of chronic device-related bacterial infections has shown that the causative organisms grow predominantly in slime-enclosed biofilms. These adherent biofilms are inherently resistant to host defences (antibodies, phagocytes) and to conventional antibiotic therapy. Device-related infections can be prevented by careful cleaning and sterilization of the device, and by the avoidance of any manipulations that would allow the formation of even the most rudimentary biofilm prior to implantation. Once a device-related infection has become established, both the Minimum Inhibitory Concentration (MIC) and the Biofilm Eliminating Concentration (BEC) of the causative organism must be determined and therapeutic strategy must aim at the use of the MIC to control the acute phase caused by planktonic bacteria and of the BEC to eliminate the biofilm nidus of infection. The removal of the colonized device should be considered early in the course of treatment if the BEC cannot be delivered to the colonized device. We describe a new bioelectric technology presently in the in vitro stage of development which, if it can be reproduced in vivo, will be very effective in the prevention and control of device-related bacterial infections.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8150522

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  8 in total

Review 1.  Biofilm consortia on biomedical and biological surfaces: delivery and targeting strategies.

Authors:  V Sihorkar; S P Vyas
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

2.  Comparative antimicrobial susceptibility of biofilm versus planktonic forms of Salmonella enterica strains isolated from children with gastroenteritis.

Authors:  K Papavasileiou; E Papavasileiou; A Tseleni-Kotsovili; S Bersimis; C Nicolaou; A Ioannidis; S Chatzipanagiotou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-07-18       Impact factor: 3.267

3.  Detection of biofilm production of Yersinia enterocolitica strains isolated from infected children and comparative antimicrobial susceptibility of biofilm versus planktonic forms.

Authors:  A Ioannidis; A Kyratsa; V Ioannidou; S Bersimis; S Chatzipanagiotou
Journal:  Mol Diagn Ther       Date:  2014-06       Impact factor: 4.074

4.  Beta androstenediol mitigates the damage of 1 GeV/n Fe ion particle radiation to the hematopoietic system.

Authors:  Roger Loria; Mathew Beckman; Daniel Contaifer; Francisco Tamariz; David Gibb; Laura Thompson; Peter Guida
Journal:  Cancer Biother Radiopharm       Date:  2011-07-26       Impact factor: 3.099

5.  A Novel Strategy for Control of Microbial Biofilms through Generation of Biocide at the Biofilm-Surface Interface.

Authors:  P Wood; M Jones; M Bhakoo; P Gilbert
Journal:  Appl Environ Microbiol       Date:  1996-07       Impact factor: 4.792

6.  Effects of ciprofloxacin and protamine sulfate combinations against catheter-associated Pseudomonas aeruginosa biofilms.

Authors:  F Soboh; A E Khoury; A C Zamboni; D Davidson; M W Mittelman
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

7.  Prevention of biofilm formation by polymer modification.

Authors:  B Jansen; W Kohnen
Journal:  J Ind Microbiol       Date:  1995-10

8.  Detection of Bacteria Bearing Resistant Biofilm Forms, by Using the Universal and Specific PCR is Still Unhelpful in the Diagnosis of Periprosthetic Joint Infections.

Authors:  Batool H Zegaer; Anastasios Ioannidis; George C Babis; Vassiliki Ioannidou; Athanassios Kossyvakis; Sotiris Bersimis; Joseph Papaparaskevas; Efthimia Petinaki; Paraskevi Pliatsika; Stylianos Chatzipanagiotou
Journal:  Front Med (Lausanne)       Date:  2014-09-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.